Stig Lenhoff (Former)
41 – 50 of 53
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Improved Response Rate with Bortezomib Consolidation After High Dose Melphalan: First Results of a Nordic Myeloma Study Group Randomized Phase III Trial
(
- Contribution to journal › Published meeting abstract
-
Mark
Impaired Stem Cell Mobilization by Fludarabine in MM: Results from a Randomized Phase II Trial
(
- Contribution to journal › Published meeting abstract
-
Mark
High-dose iodine-131-metaiodobenzylguanidine with haploidentical stem cell transplantation and posttransplant immunotherapy in children with relapsed/refractory neuroblastoma.
(
- Contribution to journal › Article
- 2008
-
Mark
Direct hospital resource utilization and costs of treating patients with multiple myeloma in Southwest Sweden: a 5-year retrospective analysis.
(
- Contribution to journal › Article
- 2007
-
Mark
Serum calcium is an independent predictor of quality of life in multiple myeloma
(
- Contribution to journal › Article
- 2006
-
Mark
Quality assessment of autografting by probability evaluation: model estimation by clinical end-points in newly diagnosed multiple myeloma patients
(
- Contribution to journal › Article
-
Mark
Serum YKL-40 concentrations in newly diagnosed multiple myeloma patients and YKL-40 expression in malignant plasma cells
(
- Contribution to journal › Article
-
Mark
Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe
(
- Contribution to journal › Article
- 2005
-
Mark
Quality of life may be affected more by disease parameters and response to therapy than by haemoglobin changes
(
- Contribution to journal › Article
-
Mark
Prognostic factors for survival in patients with advanced renal cell carcinoma undergoing nonmyeloablative allogeneic stem cell transplantation
(
- Contribution to journal › Article